건강보험심사평가원. 2018년 약제급여 적정성 평가 결과. 2019.
건강보험심사평가원. 의원 외래 약제적정성평가 가감지급사업 결과보고 – 2018년 상반기 (10차). 2019.
보건복지부. 국가 항생제 내성 관리대책: National Action Plan on Antimicrobial Resistance (2016~2020). 2016.
김지애, 이혜영, 김수진. 외래 약제 적정성 평가 가감지급 모형 개선 연구. 건강보험심사 평가원. 2017.
김지애, 이혜영, 문경준. 기타 급성 하기도감염 항생제 적정성 평가 도입 검토. 건강보험 심사평가원. 2018.
윤영경, 박찬순, 김재욱, 황규란, 이세영, 김태훈, 박도양, 김현준, 김동영, 이현종, 신형영, 유용규, 박동아, 신동우. 성인 급성 상기도 감염 항생제 사용지침 권고안. 2017.
질병관리본부. 소아 급성 상기도 감염의 항생제 사용지침. 2016.
질병관리본부. 소아 청소년 하기도 감염의 항생제 사용지침. 2017.
Amina Zafar. Patient with colds get inappropriate antibiotics in nearly half of visits to doctors, study suggests. CBC News. 2017.
Andrew M Ryan and Jan Blustein. The Effect of the MassHealth Hospital Pay-for-Performance Program on Quality. Health Serv Res.
2011;46(3):712-728.
Antonanzas F. Challenges to achieving value in drug spending in a decentralized country: the Spanish case. Value in Health. 2003;6:52–63.
Arling G, Job C, Cooke V. Medicaid nursing home pay for performance: Where do we stand? Gerontologist. 2009;49(5):587–595.
Australian Commission on Safety and Quality in Heath Care. New report provides insights into antibiotic prescribing in 151 Australian hospitals. 2013.
참고문헌
www.hira.or.kr 125 Baines DL, Brigham P, Phillips DR, Tolley KH, Whynes DK. GP fundholding
and prescribing in UK general practice: evidence from two rural, English Family health Services Authorities. Public Health. 1997;111:321–325.
Bjornsdottir I, Kristinsson KG, Hansen EH. Diagnosing infections:a qualitative view on prescription decisions in general practiceover time. Pharm World Sci. 2010;32:805-814.
Bou-Antoun S, Costelloe C, Honeyford K, Mazidi M, Hayhoe BWJ, Holmes A, Johnson AP, Aylin P. Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce use of antibiotics in the community: an interrupted time series analysis. J Antimicrob Chemother.
2018;73(10):2883-2892.
Bradlow J, Coulter A. Effect of fundholding and indicative prescribing schemes on general practitioners prescribing cost. BMJ. 1993;307(6913):1186–1189.
Burr AJ, Walker R, Stent SJ. Impact of fundholding on general practice prescribing patterns. The Pharmaceutical Journal. 1992;249.
Caroline Mercer. Education needed – for doctors and patients – to reduce inappropriate antibiotic prescriptions. CMAJ.2019;191(18):514-515.
Carter D , Charlett A, Conti S et al. A risk assessment of antibiotic pan-drug-resistance in the UK: Bayesian analysis of an expert elicitation study. Antibiotics. 2017;6:9.
Cheryl Cashin, Y-Ling Chi, Peter C. Smith, Michael Borowitz and Sarah Thomson. Paying for performance in Health Care. McGrawHill Education.
2014.
Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. 2013.
126 건강보험심사평가원
Centers for Medicare and Medicaid Services (CMS). Plan to Implement a Medicare Hospital Value-Based Purchasing Program. Report to Congress. 2007.
Chang SL, Liao JC, Shinghal R. Decreasing use of luteinizing hormone-releasing hormone agonists in the United States is Independent of Reimbursement Changes: a Medicare and Veterans Health Administration claims analysis. Journal of Urology. 2009;182:255–261.
Chou CC, Hu KY, Wu NR, Cheng YH, Loh CH, Yeh MK. Changes in drug prescription utilization for diabetic and hypertensive outpatients after initiation of the National Health Insurance’s Global Budget Program in Taiwan. Medical Science Monitor. 2008;14(5):33–39.
Chu HL, Liu SZ, Romeis JC. Changes in prescribing behaviors after implementing drug reimbursement rate reduction policy in Taiwan:
implications for the Medicare system. Journal of Health Care Finance.
2008;34(3):45–54.
Chung S, Palaniappan LP, Trujillo LM, Rubin HR, Luft HS. Effect of physician-specific pay-for-performance incentives in a large group practice. The American Journal of Managed Care. 2010;16(2):35–42.
Conrad DA, Christianson JB. Penetrating the “black box”: financial incentives for enhancing the quality of physician services. Medical Care Research and Review. 2004;61(3):37–68.
Costelloe C, Metcalfe C, Loveing A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta analysis. BMJ. 2010;340.
Coulter A, Bradlow J. Effect of NHS reforms on general practitioners’ referral patterns. BMJ. 1993;306:433–437.
Damberg CL, Sorbero ME, Mehrotra A, Teleki S, Lovejoy S, and Bradley L. An Environmental Scan of Pay for Performance in the Hospital Setting: Final Report. Rand Health. 2007.
참고문헌
www.hira.or.kr 127 Damberg CL, Sorbero ME, Lovejoy SL, Martsolf GR, Raaen L, Mandel D.
Measuring Success in Health Care Value-Based Purchasing Programs:
Findings from an Environmental Scan, Literature Review, and Expert Panel Discussions. Rand Health. 2014;4(3):9.
Deci EL, Koestner R, Ryan RN. A Meta-Analytic Review of Experiments Examining the Effects of Extrinsic Rewards on Intrinsic Motivation.
Psychological Bulletin 1999;125(6):627–668; discussion 692–700.
Dekker ARJ, Verheij TJM, van der Velden AW. Inappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patients. Fam Pract. 2015;32:401-407.
De Kraker MEA, Jarlier V, Monen JCM et al. The changing epidemiology of bacteraemias in Europe: trends from the European antimicrobial resistance surveillance system. Clin Microbiol Infect 2013;19:860-868.
Del Mar CB, Scott AM, Glasziou PP, Hoffmann T, van Driel ML, Beller E, Phillips SM, Dartnell J. Reducing antibiotic prescribing in Australian general practice: time for a national strategy. Med J Aust.
2017;207(9):401-406.
Department of Health and Social Care. UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018. 2013.
Doran T, Kontopantelis E, Valderas JM, Campbell S, Roland M, Salisbury C, et al. Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework. British Medical Journal. 2011;342:3590.
Dudley RA. Pay-for-performance research: How to learn what clinicians and policy makers need to know. JAMA. 2005;294(14):1821–1823.
Eijkenaar, F. Key issues in the design of pay-for-performance programs.
European Journal of Health Economics. 2013;14(1):117-131.
128 건강보험심사평가원
European Commission (EC). Action Plan against the rising threats from Antimicrobial Resistance (AMR). 2011.
Finley R, Glass-Kaastra SK, Hutchinsaon J, Patrick DM, Weiss K, Conly J.
Declines in outpatient antimicrobial use in Canada (1995-2010). PLoS ONE. 2013;8(10).
Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA,File TM Jr, et al. Prevalence of inappropriate antibiotic pre-scriptions among US ambulatory care visits. 2010-2011. JAMA. 2016;315:1864-1873.
Freedman JL, Cunningham JA, Krismer K. Inferred Values and the Reverse-Incentive Effect in Induced Compliance. Journal of Personality and Social Psychology. 1992;62(3):357–368.
Granlund D, Rudholm N, Wikström M. Fixed bud gets as a cost containment measure for pharmaceuticals. The European Journal of Health Economics.
2006;7(1):35–45.
Guether B. Effects of German health legislation on the prescriptions of GPs [Auswirkungen des GSG auf das Verordnungsverhalten niedergelassener Aerzte]. Gesundheitswesen 1995;57:185–191.
Goverment UK. G7 2016 in Japan. PM Press Statement.2016
Gulliford MC, Dregan A, Moore MV et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ. 2014;4.
Harbarth S, Balkhy HH, Goossens H, Jarlier V, Kluytmans J, Laxminarayan R.
et al. Antimicrobial resistance: one world, one fight! Antimicrobal Resistance Infection Control. 2015;4.
Harrison S, Choudhry N. General practice fundholding in the UK National Health Service: evidence to date. Journal of Public Health Policy.
1996;17(3):331–346.
참고문헌
www.hira.or.kr 129 Hawker JI, Smith S, Smith GE et al. Trends in antibiotic prescribing in
primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995-2011: analysis of a large database of primary care consultations. J Antimicrob Chemother.
2014;69:3423-3430.
Hick LA, Bartoces MG, Roberts RM, et al. US outpatient antibiotic prescribing bariation according to geography, patient population, and provider speciality in 2011. Clin Infect Dis. 2015;60(9):1308-1316.
HM Government. Tackling antimicrobial resistance 2019-2014: The UK’s five-year national action plan. 2019.
Holmstrom B, Milgrom P. Multitask Principal-Agent Analyses: Incentive Contracts, Asset Ownership, and Job Design. Journal of Law, Economics, and Organization. 1991;7:24–52.
IHA (Integrated Healthcare Association). California pay for performance program: incentive payouts. 2010.
IHA (Integrated Healthcare Association). Integrated Healthcare Association California Value Based Pay for Performance Program: Measurement Year 2018: VBP4P Manual. 2019.
IHA (Integrated Healthcare Association). Pay for performance report of results for measurement year 2010. 2012.
Kahneman D, Tversky A. Prospect Theory: An Analysis of Decision Under Risk. Econometrica. 1979;47(2):263–292.
Linder JA. Editorial commentary: antibiotics for treatment of acute respiratory tract infections: decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance. Clin Infect Dis. 2008;47(6):774-746.
Lowenstein R. Exuberance Is Rational. New York Times Magazine. 2011.
130 건강보험심사평가원
Martens JD, Werkhoven MJ, Severens JL, Winkens RA. Effects of a behaviour independent nancial incentive on prescribing behaviour of general practitioners. Journal of Evaluation in Clinical Practice. 2007;13(3):369–373.
MassHealth Office of Acute and Ambulatory Care, Commonwealth of Massachusetts Executive Office of Health and Human Services. 2009.
McCullough AR, Pollack AJ, Plejdrup Hansen M, Glasziou PP,Looke DF, Britt HC. et al. Antibiotics for acute respiratory infec-tions in general practice:
comparison of prescribing rates with guideline recommendations. Med J Aust. 2017;207:65-69.
McNamara P. Quality-based payment: six case examples. International Journal of Quality Health Care. 2005;17(4):357–362.
Mehrotra A, Damberg CL, Sorbero MES, Teleki SS. Pay for Performance in the Hospital Setting: What Is the State of the Evidence? American Journal of Medical Quality. 2009;24(1):19-28.
Metlay JP. Editorial commentary: setting national targets for antibiotic use.
Clin Infect Dis. 2015;60(9):1317-1318.
Mossialos E, Walley T, Rudisill C. Provider incentives and prescribing behavior in Europe. Expert Review on Pharmacoeconomics and Outcomes Research 2005;5(1):81–93.
Neumark T , Brudin L, Engstrom S et al. Trends in number of consultations and antibiotic prescriptions for respiratory tract infections between 1999 and 2005 in primary healthcare in Kalmar County, Southern Sweden.
Scand J Prim Health Care. 2009;27:18-24.
Neumark T , Brudin L, Molstad S. Use of rapid diagnostic tests and choice of antibiotics in respiratory tract infections in primary healthcare? Scand J Infect Dis. 2010;42:90-96.
NHS England. Quality Premium Guidance for 2015/16. 2015.
NHS England. Quality Premium Guidance for 2016/17. 2016.
참고문헌
www.hira.or.kr 131 NHS England. Quality Premium Guidance for 2018/19. 2019.
NHS England and NHS Improvement. Commissioning for Quality and Innovation (CQUIN): Guidance for 2017-2019. 2018.
OECD. OECD Health Statistics 2019.
OECD. OECD Survey on Health System Characteristics. 2016.
O’Malley AJ, Frank RG, Kaddis A, Rothenberg BM, McNeil BJ. Impact of alternative interventions on changes in generic dispensing rates. Health Services Research 2006;41(5):1876–1894.
O’Neill J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. Review on Antimicrobial Resistance. 2014.
Petersen I, Hayward AC. SACAR: Surveillance Subgroup - Antibacterial prescribing in primary care. J Antimicrob Chemother. 2007;60:43-47.
Public Health Agency of Canada. Canadian Antimicrobial Resistance Surveillance System 2017 Report. 2017.
Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR). 2016.
Rafferty T. Wilson-Davis K, McGavock H. How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study. BMJ.
1997;315:166–170.
Rashidian A, Omidvari AH, Vali Y, SturmH, Oxman AD. Pharmaceutical policies: effects of financial incentives for prescriberS (Review). Cochrane Database of Systematic Reviews 2015;8.
Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M. Antimicrobial drug use and resistance in Europe.
Emerg Infect Dis. 2008;14:1722–1730.
132 건강보험심사평가원
Schreyögg J, Busse R. Physician drug budgets in Germany: effects on prescription behaviour. Journal of Pharmaceutical Finance. 2005;14(3):77–95.
Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, Zhang F, et al. Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom:interrupted time series study. British Medical Journal. 2011;342:108.
Swedres-Svarm. Swedres-Svarm Reports. 2014.
Takian A, Rashidian A, Kabir MJ. Expediency and coincidence in re-engineering a health system: an interpretive approach to formation of family medicine in Iran. Health Policy Plan. 2011;26(2):163–73.
The government of Japan. National Action Plan on Antimicrobial Resistance (AMR) 2016-2020. 2016.
The White House. National Strategy for Combating Antibiotic-Resistant Bacteria. 2014.
The White House. National action plan for combating antibiotic-resistant bacteria. 2016.
Walley T, Murphy M, Codd M, Johnston Z, Quirke T. Effects of monetary incentive on primary care prescribing in Ireland: changes in prescribing patterns in one health board 1990-1995. Pharmacoepidemiology and Drug Safety. 2000;9:591–598.
WHO (World Health Organization). Antibiotic resistance; Geveva, Switzerland.2012;194.
WHO (World Health Organization). Global Action Plan on Antimcrobial Resistance. 2015.
Whynes DK, Baines DL, Tolley KH. GP fundholding and the costs of prescribing: further results. Journal of Public Health Medicine 1997;19(1):18–22.
참고문헌
www.hira.or.kr 133 Wilson RP, Buchan I, Walley T. Alterations in prescribing by general
practitioner fundholders: an observational study. BMJ.
1995;311(7016):1347–1350.
Wilson RP, Hatcher J, Barton S, Walley T. General practice fundholders’
prescribing savings in one region of the United Kingdom. Health Policy.
1997;42:29–37.
Wilson RPH, Hatcher J, Barton S, Walley T. Therapeutic substitution and therapeutic conservatism as cost containment strategies in primary care: a study of fundholders and non-fundholders. British Journal of General Practice. 1999;443:431–5.
Wilton P, Smith RD. Primary care reform: a three country comparison of
’budget holding’. Health Policy. 1998;44(2):149–166.
Yegian J, Yanagihara D. Value Based Pay for Performance in California. IHA Issue Brief. 2013.